Label: SB5 (BIIB606)- adalimumab-bwwd injection, solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated October 31, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • PRINCIPAL DISPLAY PANEL

    LBL168-100-002LBL168-100-002LBL168-100-002LBL168-100-002

  • INGREDIENTS AND APPEARANCE
    SB5 (BIIB606) 
    adalimumab-bwwd injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61434-005
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ADALIMUMAB-BWWD (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842) ADALIMUMAB-BWWD40 mg  in 0.8 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61434-005-001280 in 1 CASE08/27/2017
    10.8 mL in 1 SYRINGE, GLASS; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    export only08/27/2017
    Labeler - Catalent Indiana, LLC (172209277)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!